Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER_GOV 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Breast 2Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Osteoporosis 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Alendronate × Breast × Clear all
NCT00354302 2020-04-02

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Canadian Cancer Trials Group

Phase 3 Completed
497 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00122356 2013-03-13

BATMAN

Barwon Health

Phase 3 Completed
303 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡